Epstein Secrets

ments causes significant concerns about how reasonable they are in practice. Full transparency requires the DOJ to release the same dataset used by Grant Duwe, Ph.D., and Zachary Hamilton, Ph.D., to create PATTERN.14 This is consistent not only with the transparency directives in the FSA,l5 but also with th

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00100213 EXHIBIT B EFTA00100214

ments causes significant concerns about how reasonable they are in practice. Full transparency requires the DOJ to release the same dataset used by Grant Duwe, Ph.D., and Zachary Hamilton, Ph.D., to create PATTERN.14 This is consistent not only with the transparency directives in the FSA,l5 but also with th

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00064950 EXHIBIT B EFTA00064951

ments causes significant concerns about how reasonable they are in practice. Full transparency requires the DOJ to release the same dataset used by Grant Duwe, Ph.D., and Zachary Hamilton, Ph.D., to create PATTERN.14 This is consistent not only with the transparency directives in the FSA,l5 but also with th

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00094068 EXHIBIT B EFTA00094069